• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 99-113 of 361 results

No. 44 NOTICE OF SERVICE of (i) University of Massachusetts and Carmel Laboratories, LLC's Amended ...

Document University of Massachusetts et al v. L'Oreal U.S.A., Inc., 1:17-cv-00868, No. 44 (D.Del. Jul. 19, 2019)
Attorneys for University of Massachusetts and Carmel Laboratories, LLC
cite Cite Document

3 Notice of Filing Date Accorded to Petition: Notice of Accord Filing Date

Document IPR2018-00778, No. 3 Notice of Filing Date Accorded to Petition - Notice of Accord Filing Date (P.T.A.B. Mar. 21, 2018)
For more information, please consult the Office Patent Trial Practice Guide, 77 Fed. Reg. 48756 (Aug. 14, 2012), which is available on the Board Web site at http://www.uspto.gov/PTAB.
Patent Owner is advised of the requirement to submit mandatory notice information under 37 C.F.R. § 42.8(a)(2) within 21 days of service of the petition.
The parties are advised that under 37 C.F.R. § 42.10(c), recognition of counsel pro hac vice requires a showing of good cause.
Many non-profit organizations, both inside and outside the intellectual property field, offer alternative dispute resolution services.
If the parties actually engage in alternative dispute resolution, the PTAB would be interested to learn what mechanism (e.g., arbitration, mediation, etc.) was used and the general result.
cite Cite Document

No. 43 NOTICE OF SERVICE of (i) University of Massachusetts and Carmel Laboratories, LLC's First Set ...

Document University of Massachusetts et al v. L'Oreal U.S.A., Inc., 1:17-cv-00868, No. 43 (D.Del. Jul. 15, 2019)
Attorneys for University of Massachusetts and Carmel Laboratories, LLC DATED: July 15, 2019
Attorneys for Carmel Laboratories, LLC Attorney for University of Massachusetts
cite Cite Document

No. 42

Document University of Massachusetts et al v. L'Oreal U.S.A., Inc., 1:17-cv-00868, No. 42 (D.Del. Jul. 15, 2019)

cite Cite Document

No. 37 STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the complaint to June 14, ...

Document University of Massachusetts et al v. L'Oral U.S.A., Inc., 1:17-cv-00868, No. 37 (D.Del. May. 30, 2019)
Motion to Extend Time
UNIVERSITY OF MASSACHUSETTS and
IT IS HEREBY STIPULATED AND AGREED, by and between Plaintiffs and L’Oréal USA, Inc., through their undersigned counsel and subject to the approval of the Court, that the deadline for L’Oréal USA, Inc. to move, answer or otherwise respond to the complaint is hereby extended through and including June 14, 2019.
SO ORDERED this ________ day of ___________, 2019.
United States Magistrate Judge
cite Cite Document

No. 23 MOTION to Dismiss for Lack of Jurisdiction Over the Person and for Failure to State a Claim ...

Document University of Massachusetts Medical School et al v. L'Oreal S.A. et al, 1:17-cv-00868, No. 23 (D.Del. Oct. 16, 2017)
Motion to Dismiss for Lack of Jurisdiction
MEDICAL SCHOOL and CARMEL
Defendant L’Oréal S.A. (“L’Oréal S.A.”), by and through its undersigned counsel, hereby moves to dismiss the First Amended Complaint (D.I.
13) pursuant to Federal Rule of Civil Procedure (“Rule”) Rule 12(b)(2), for lack of personal jurisdiction, and Rule 12(b)(6), for failure to state a claim upon which relief can be granted (the “Motion”).
The grounds for this Motion are set forth fully in L’Oréal S.A.’s Opening Brief filed contemporaneously herewith, as well as the Declaration of Roy Rabinowitz.
cite Cite Document

No. 13 First AMENDED COMPLAINT against L'Oreal S.A., L'Oreal USA, Inc.- filed by University of Massachusetts ...

Document University of Massachusetts Medical School et al v. L'Oreal S.A. et al, 1:17-cv-00868, No. 13 (D.Del. Aug. 18, 2017)
Complaint
Dr. James G. Dobson, Jr., a renowned cardiovascular physiologist and the former Chairman of the Department of Physiology at the University of Massachusetts Medical School, has been conducting research on adenosine since approximately the mid 1960’s.
Easeamine was initially released in 2009 and, due to its innovative and unique properties, received favorable press in newspapers around the world, leading to significant sales in its first year.
Based on the strength of initial sales, Carmel Labs reinvested substantial sums— obtained in part by leveraging property owned by the monastery—to expand the Easeamine line.
Carmel Labs retained experienced cosmetic industry professionals as well as a contract manufacturer and a branding and public relations firm to assist in creating and marketing a full Easeamine product line, with an anticipated release date in fall of 2010.
Due to public focus on Defendants’ adenosine products, projected sales of Easeamine did not materialize, resulting in lost revenue to Carmel Labs, and ultimately, to Teresian Carmelites.
cite Cite Document

6 Motion: Patent Owners Unopposed Motion For District Court Type Claim Construc...

Document IPR2018-00778, No. 6 Motion - Patent Owners Unopposed Motion For District Court Type Claim Construction In Accordance With 37 CFR Section 41100b (P.T.A.B. Apr. 27, 2018)

cite Cite Document

13 Refund Request: Petitioners Request for Refund for Non Instituted Case

Document IPR2018-00778, No. 13 Refund Request - Petitioners Request for Refund for Non Instituted Case (P.T.A.B. Dec. 17, 2018)

cite Cite Document

2 Petition: PETITION FOR INTER PARTES REVIEW OF US PATENT NO 6,423,327

Document IPR2018-00778, No. 2 Petition - PETITION FOR INTER PARTES REVIEW OF US PATENT NO 6,423,327 (P.T.A.B. Mar. 15, 2018)

cite Cite Document

11 Rehearing Request in re Petition Institution Decision Denied: PETITIONERS CO...

Document IPR2018-00778, No. 11 Rehearing Request in re Petition Institution Decision Denied - PETITIONERS CORRECTED REQUEST FOR REHEARING (P.T.A.B. Oct. 11, 2018)

cite Cite Document

10 Rehearing Request in re Petition Institution Decision Denied: PETITIONER¿¿¿S R...

Document IPR2018-00778, No. 10 Rehearing Request in re Petition Institution Decision Denied - PETITIONER¿¿¿S REQUEST FOR REHEARING (P.T.A.B. Oct. 9, 2018)

cite Cite Document

8 Mandatory Notice: Patent Owner Updated Mandatory Notices Under 37 CFR Sect...

Document IPR2018-00778, No. 8 Mandatory Notice - Patent Owner Updated Mandatory Notices Under 37 CFR Section 428 (P.T.A.B. Jul. 30, 2018)

cite Cite Document

7 Preliminary Response: Patent Owner Preliminary Response

Document IPR2018-00778, No. 7 Preliminary Response - Patent Owner Preliminary Response (P.T.A.B. Jun. 21, 2018)

cite Cite Document

4 Power of Attorney: Patent Owner Power of Attorney

Document IPR2018-00778, No. 4 Power of Attorney - Patent Owner Power of Attorney (P.T.A.B. Apr. 5, 2018)

cite Cite Document
<< 1 2 3 4 5 ... 7 8 9 10 11 ... >>